I think this is exciting news. The OTC Listing in the USA is a great jump for us here. Getting out 2mil worth of samples can only mean repeat sales. The market is ready for this IMO. Once the marketing starts and this product is known, I think it will sell, I want to buy one already, and that is just after reading the clinical trial data of phase 2. ArtemiC is going to be a winner in my opinion...
I think this is exciting news. The OTC Listing in the USA is a...
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RGT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
-0.025(7.58%) |
Mkt cap ! $14.76M | |||
| Open | High | Low | Value | Volume |
| 30.0¢ | 30.5¢ | 30.0¢ | $1.48K | 4.929K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | 30.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 823 | 3 |
View Market Depth
| Last trade - 15.11pm 30/08/2024 (20 minute delay) ? |
| RGT (ASX) Chart |